Cow urine to be used in medicines and treatment of cancer: Health Minister Ashwini Choubey
Ashwini Kumar Choubey said the urine of the indigenous variety of cow is often used and that the Ministry of AYUSH is seriously working on it. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 8, 2019 Category: Pharmaceuticals Source Type: news

Need ED's satisfaction over dues payments made by Sterling promoters: NCLAT
The tribunal also said the promoters will have to settle their case with the creditors within a specified period. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 6, 2019 Category: Pharmaceuticals Source Type: news

Lupin signs second partnership for its oncology pipeline, this time with German drug maker BI
BI and Lupin will together develop and commercialise a new drug called MEK inhibitor that will target specific cancer cells and potentially treat patients of skin and stomach cancer. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 4, 2019 Category: Pharmaceuticals Source Type: news

Sterling Biotech case: Far-reaching NCLAT order sets new bankrupcty precedent
The company's promoters, Chetan Sandesara and Nitin Sandesara, are absconding and believed to be in Africa. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 4, 2019 Category: Pharmaceuticals Source Type: news

Novartis's Sandoz licenses proposed multiple sclerosis biosimilar
The medicine is in Phase III clinical development for the treatment of relapsing-remitting multiple sclerosis (RRMS). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 3, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues response letter for new drug application for insulin glargine: Biocon
Biocon is confident of addressing these observations through a corrective and preventive action plan in a timely manner, it added. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 31, 2019 Category: Pharmaceuticals Source Type: news

Oxxy Healthcare to offer up to Rs 1,000 crore loan for medical treatment in FY20
There will be no processing fee and the application will be processed within hours, Oxxy Healthcare said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 30, 2019 Category: Pharmaceuticals Source Type: news

Granules India to divest entire stake in Granules OmniChem to JV partner
SA Ajinomoto Omnichem NV will take over full control of the contract research and manufacturing services (CRAMS) business, said Granules India. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues warning letter to Lantech Pharma for manufacturing violations at Andhra plant
In a warning letter issued to the company's Managing Director V Prakash Reddy, the USFDA said inspectors during March 6-15 this year found significant deviations from standard manufacturing practices at the company's Ranastalam (Srikakulam district) based plant. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 29, 2019 Category: Pharmaceuticals Source Type: news

Pharma company accountant held for sharing its data with rival firm
Mahaveer Pharma, a firm based in Chamrajpet, detected that data of all its transactions between April 1 and July 22 had been sent to an unknown person via email. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2019 Category: Pharmaceuticals Source Type: news

China's new drug law may open door for Indian generic medicines: Report
No major Indian pharma company managed to establish itself in China in view of the rigid regulations and the costs involved. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 27, 2019 Category: Pharmaceuticals Source Type: news

Lupin's South African arm inks commercial pact with Creso Pharma
Shares of Lupin Ltd closed at Rs 747.30 per scrip on the BSE, up 1.21 per cent from its previous close. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 26, 2019 Category: Pharmaceuticals Source Type: news

Chennai startup Eywa enters US pharma market
Eywa Pharma, based in Chennai and with offices in New Jersey, is the new pharma kid on the block that is entering the US market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2019 Category: Pharmaceuticals Source Type: news

Central drug regulator preparing list of dual-use APIs imported from unregistered firms
Dual-use APIs, which are being imported from unregistered companies, are comparatively cheaper and of low-quality. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2019 Category: Pharmaceuticals Source Type: news

Glenmark recalls products from US market
Glenmark Pharmaceuticals Inc USA is recalling 31,224 tubes of Clotrimazole and Betamethasone Dipropionate cream. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 25, 2019 Category: Pharmaceuticals Source Type: news

Glenmark in talks to sell up to 30% in API biz to PremjiInvest
Discussions are ongoing with True North (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2019 Category: Pharmaceuticals Source Type: news

Why Indian pharma needs more expats on boards
Expats at the helm can help improve corporate governance and transparency (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2019 Category: Pharmaceuticals Source Type: news

Johnson & Johnson pays Rs 25 lakh each to three victims of faulty hip implants
Pharma major Johnson& Johnson has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh, officials said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 23, 2019 Category: Pharmaceuticals Source Type: news

Biocon's Malaysian arm gets EU GMP certification for insulin manufacturing facility
The integrated insulins facility in Malaysia manufactures drug substance and drug products in vials, cartridges, and insulin delivery devices was inspected in May 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 22, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic oral anti-epileptic drug in US
The product is a generic version of Lundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing to the BSE. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 20, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches Roche's Avastin biosimilar in India
The launch of Versavo is another step in that journey and helps in strengthening the company's oncology portfolio. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 19, 2019 Category: Pharmaceuticals Source Type: news

USFDA okays new antibiotic for highly drug-resistant tuberculosis
Pretomanid, a new chemical entity, was under development since 2002 by the TB Alliance. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 16, 2019 Category: Pharmaceuticals Source Type: news

Sun, CSIR-IICT Ink Global Licensing Pact for Patents
'This collaboration with CSIRIICT for developing new drugs is part of our broader strategy for enhancing our global specialty pipeline.' (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 15, 2019 Category: Pharmaceuticals Source Type: news

Pharma wants a booster fund to push innovation
Indian Pharmaceutical Alliance seeks to promote innovation backed by risk capital. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 15, 2019 Category: Pharmaceuticals Source Type: news

USFDA issues 6 observations to Natco Pharma's API facility near Hyderabad
The United States Food and Drug Administration (USFDA) conducted inspection at Kothur facility between August 5-9, 2019. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 12, 2019 Category: Pharmaceuticals Source Type: news

Unichem Laboratories gets USFDA nod for hypertension management drug
The approved product is a generic version of Hygroton tablets, 25 mg and 50 mg of Sanofi Aventis US, LLC. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 12, 2019 Category: Pharmaceuticals Source Type: news

Facing headwinds in US, Natco Pharma looks to scale up business in China
In the near term, the pharmaceutical company would continue to be driven by markets like India, Brazil and Canada. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 11, 2019 Category: Pharmaceuticals Source Type: news

At Rs 58.8 cr, Murali of Divi's Lab highest paid Indian pharma executive
The percentage increase in the median remuneration for the staff of the firm for FY19 was 3.96 per cent. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 11, 2019 Category: Pharmaceuticals Source Type: news

Not withholding interim compensation from patients who want more: Johnson and Johnson to HC
The submission by the company came in response to a query by Justice Vibhu Bakhru as to what was it doing in cases where patients want more than the Rs 25 lakh. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 8, 2019 Category: Pharmaceuticals Source Type: news

US senator seeks unannounced inspections of foreign drug manufacturing units in India and China
The chairman of the Senate Finance Committee said this was needed as these facilities provided most of the ingredients for production inside the US. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 8, 2019 Category: Pharmaceuticals Source Type: news

NCLAT stays eviction of Sterling Biotech from its premise
Besides, the appellate tribunal also said that "the Liquidator cannot sell the assets of the premises in question." (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 4, 2019 Category: Pharmaceuticals Source Type: news

Sun Pharma shuts 2 Gujarat R & D centres to cut costs
Sources said the company ’s R&D centre at Gurgaon (started by erstwhile Ranbaxy) will now undertake the clinical research handled by the Vadodara facility (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 3, 2019 Category: Pharmaceuticals Source Type: news

Mylan deal to give a boost to Pfizer ’s India business: Analysts
On Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share of the new company. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 31, 2019 Category: Pharmaceuticals Source Type: news

Warning letter woes: Dr Reddy's expects FDA inspection of AP plant by year-end
USFDA had issued warning letter in November 2015 relating to Current Good Manufacturing Practice deviations at DR Reddy's API manufacturing facilities at Srikakulam. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 30, 2019 Category: Pharmaceuticals Source Type: news

Strides inks JV pact with China's Sihuan Pharma
Sihuan will leverage its over 4,000 strong sales force and 3,000 plus distributors across Mainland China to market the products. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 29, 2019 Category: Pharmaceuticals Source Type: news

Cipla seeks favourable policy for domestic pharma cos, ease of doing biz
Cipla Executive Vice-Chairperson Samina Vaziralli said with the government returning for a second consecutive five-year term armed with a strong mandate, expectations are high. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 28, 2019 Category: Pharmaceuticals Source Type: news

Alkem Laboratories founder Samprada Singh passes away
Singh was a pharma industry veteran with over 43 years of experience in the Indian pharmaceutical industry. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2019 Category: Pharmaceuticals Source Type: news

NCLAT stays sale of Orchid to Dhanuka
In response to a petition filed by Accord Life Spec Private Ltd, a company promoted by DMK MP Jagatrakshagan ’s family members, the NCLAT stayed the bids. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 27, 2019 Category: Pharmaceuticals Source Type: news

Pakistan imports over $36 million worth of anti-rabies, anti-venom vaccines from India
Pakistan was buying the vaccines despite the chill in bilateral ties, especially after the Pulwama terror attack by a suicide bomber belonging to Pakistan-based Jaish-e-Mohammed terrorist. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2019 Category: Pharmaceuticals Source Type: news

Indoco Remedies gets EIR from USFDA for 2 plants in Goa
"We are happy to receive the EIR in less than two months from the date of inspection," Indoco Remedies MD Aditi Kare Panandikar said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 26, 2019 Category: Pharmaceuticals Source Type: news

Mega diabetes drug to be cheaper soon
With Novartis losing patent protection for Vildagliptin in December, the cost of therapy is expected to reduce by over 50%. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 25, 2019 Category: Pharmaceuticals Source Type: news

Zydus Cadila launches insomnia drug in US market
Ramelteon is used to treat insomnia that is associated with having trouble falling asleep. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 24, 2019 Category: Pharmaceuticals Source Type: news

Alembic Pharma gets tentative nod from USFDA for glycemic control drug
Quoting IQVIA sales data, the company said, Dapagliflozin Tablets, have an estimated market size of USD 1.7 billion for 12 months, ending December 2018. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 23, 2019 Category: Pharmaceuticals Source Type: news

Health Ministry proposes minimum standards for clinical establishments
Clinical Establishment (Registration and Regulation) Act, 2010, makes registration a must for running a clinical establishment. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 21, 2019 Category: Pharmaceuticals Source Type: news

USFDA completes inspection of Strides Pharma Bengaluru plant
The company's facility in Bengaluru underwent a United States Food and Drug Administration (USFDA) inspection that ended on May 24, 2019, Strides Pharma Science said in a statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 20, 2019 Category: Pharmaceuticals Source Type: news

Dr Reddy's launches generic version of Allegra D in US
"We are pleased to be expanding our pseudoephedrine-based product offering in time for the cough, cold and allergy season," Dr Reddy's Senior VP says. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 19, 2019 Category: Pharmaceuticals Source Type: news

Cabinet okays Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities
Of the Rs 330.35 crore, Rs 158.35 crore will be utilised to clear unpaid salary and Rs 172 crore for meeting the VRS liability. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

NHA looks to make Ayushman Bharat more viable
The idea behind this policy is to lower purchase costs for hospitals, helping make the procedure rates sustainable. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

US FDA finds "significant violations" at India's Strides plant
The drugmaker was caught trying to dispose quality-control records, the FDA said in a letter made public on July 16. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 17, 2019 Category: Pharmaceuticals Source Type: news

Cipla forms JV with Jiangsu Acebright for respiratory medicines in China
The agreement is between Chinese firm Jiangsu Acebright and Cipla's European arm, Cipla EU for a combined investment of USD 30 million, as per a company statement. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - July 16, 2019 Category: Pharmaceuticals Source Type: news